Raymond James Financial Inc. bought a new position in shares of Transcat, Inc. (NASDAQ:TRNS – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm bought 19,587 shares of the scientific and technical instruments company’s stock, valued at approximately $2,071,000.
Other institutional investors have also recently made changes to their positions in the company. Intech Investment Management LLC acquired a new position in shares of Transcat during the third quarter worth approximately $235,000. Charles Schwab Investment Management Inc. increased its stake in Transcat by 2.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 74,832 shares of the scientific and technical instruments company’s stock valued at $9,037,000 after purchasing an additional 2,008 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in Transcat by 64.0% during the third quarter. BNP Paribas Financial Markets now owns 22,661 shares of the scientific and technical instruments company’s stock worth $2,737,000 after buying an additional 8,844 shares during the last quarter. Glenmede Trust Co. NA lifted its stake in shares of Transcat by 17.2% in the third quarter. Glenmede Trust Co. NA now owns 4,593 shares of the scientific and technical instruments company’s stock valued at $555,000 after buying an additional 675 shares in the last quarter. Finally, Walleye Capital LLC acquired a new position in shares of Transcat during the third quarter valued at about $216,000. Institutional investors own 98.34% of the company’s stock.
Insiders Place Their Bets
In other news, Director Craig D. Cairns bought 1,200 shares of the firm’s stock in a transaction on Friday, January 31st. The shares were bought at an average price of $77.02 per share, for a total transaction of $92,424.00. Following the purchase, the director now owns 1,910 shares in the company, valued at approximately $147,108.20. The trade was a 169.01 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.30% of the stock is owned by insiders.
Transcat Stock Up 0.6 %
Transcat (NASDAQ:TRNS – Get Free Report) last posted its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same quarter last year, the company earned $0.56 EPS. Sell-side analysts forecast that Transcat, Inc. will post 2.3 earnings per share for the current year.
Analyst Ratings Changes
Several brokerages have recently commented on TRNS. Craig Hallum increased their price objective on Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a research note on Thursday, December 12th. Northland Securities reissued a “market perform” rating and issued a $85.00 price target (down from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. HC Wainwright cut their price objective on shares of Transcat from $126.00 to $106.00 and set a “buy” rating on the stock in a report on Wednesday, January 29th. StockNews.com downgraded shares of Transcat from a “hold” rating to a “sell” rating in a report on Wednesday, February 5th. Finally, Oppenheimer lowered shares of Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $111.50.
Read Our Latest Analysis on TRNS
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Articles
- Five stocks we like better than Transcat
- Growth Stocks: What They Are, What They Are Not
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- 5 Top Rated Dividend Stocks to Consider
- MarketBeat Week in Review – 03/24 – 03/28
- Transportation Stocks Investing
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Want to see what other hedge funds are holding TRNS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Transcat, Inc. (NASDAQ:TRNS – Free Report).
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.